| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Potassium channel subfamily K member 2 |
|---|
| Ligand | BDBM30130 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1584408 (CHEMBL3819951) |
|---|
| IC50 | 19000±n/a nM |
|---|
| Citation |  Vivier, D; Bennis, K; Lesage, F; Ducki, S Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target? J Med Chem59:5149-57 (2016) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Potassium channel subfamily K member 2 |
|---|
| Name: | Potassium channel subfamily K member 2 |
|---|
| Synonyms: | KCNK2 | KCNK2_HUMAN | Outward rectifying potassium channel protein TREK-1 | TREK | TREK-1 K(+) channel subunit | TREK1 | Twik-RElated Potassium (K+) channel 1 (TREK1) | Two pore domain potassium channel TREK-1 | Two pore potassium channel TPKC1 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 47099.16 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O95069 |
|---|
| Residue: | 426 |
|---|
| Sequence: | MLPSASRERPGYRAGVAAPDLLDPKSAAQNSKPRLSFSTKPTVLASRVESDTTINVMKWK
TVSTIFLVVVLYLIIGATVFKALEQPHEISQRTTIVIQKQTFISQHSCVNSTELDELIQQ
IVAAINAGIIPLGNTSNQISHWDLGSSFFFAGTVITTIGFGNISPRTEGGKIFCIIYALL
GIPLFGFLLAGVGDQLGTIFGKGIAKVEDTFIKWNVSQTKIRIISTIIFILFGCVLFVAL
PAIIFKHIEGWSALDAIYFVVITLTTIGFGDYVAGGSDIEYLDFYKPVVWFWILVGLAYF
AAVLSMIGDWLRVISKKTKEEVGEFRAHAAEWTANVTAEFKETRRRLSVEIYDKFQRATS
IKRKLSAELAGNHNQELTPCRRTLSVNHLTSERDVLPPLLKTESIYLNGLTPHCAGEEIA
VIENIK
|
|
|
|---|
| BDBM30130 |
|---|
| n/a |
|---|
| Name | BDBM30130 |
|---|
| Synonyms: | CHEMBL1201082 | CHEMBL41 | Fluoxetin | Fluoxetine | Prozac | US9120771, Fluoxetine | cid_62857 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H18F3NO |
|---|
| Mol. Mass. | 309.3261 |
|---|
| SMILES | CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1 |
|---|
| Structure | 
|
|---|
Search and Browse
